Page last updated: 2024-11-02

oxaprozin and Uremia

oxaprozin has been researched along with Uremia in 1 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jusko, WJ1
Chiang, ST1

Other Studies

1 other study available for oxaprozin and Uremia

ArticleYear
Distribution volume related to body weight and protein binding.
    Journal of pharmaceutical sciences, 1982, Volume: 71, Issue:4

    Topics: Body Weight; Humans; Kinetics; Models, Biological; Oxaprozin; Oxazoles; Pharmaceutical Preparations;

1982
chemdatabank.com